cardiovascular disease treatment

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

More than 10.000 documents for cardiovascular disease treatment

- Hodgkin Lymphoma Patients with Cardiovascular Disease Have Increased Risk of Post-Treatment Cardiac Hospitalization
WASHINGTON, July 1 /PRNewswire-USNewswire/ -- Older patients with Hodgkin lymphoma (HL) and a history of heart disease face a high risk of hospitalization for cardiac complications after completing treatment, according to research published online today in Blood, the journal of the American Society of Hematology. HL is a form of cancer of arising in the lymph nodes, and approximately 8,500 people were diagnosed with the disease in 2009, according to the American Cancer Society. Treatment for HL typically includes the drug doxorubicin as part of chemotherapy and may also include radiation therapy to lymph nodes in the chest. Although treatment produces high cure rates, these treatments can also be toxic to the heart. This makes treating patients with pre-existing heart disease particular...
- U.S. Newswire
- July 01, 2010
- Initiative Helps Close Treatment Gap in Secondary Prevention of Cardiovascular Disease and Primary Prevention of Stroke
The recognition signifies that each of Tenet South Florida's 14 acute care hospitals is participating in the American Heart Association Get With The Guidelines program," said Tony Newbold, AHA affiliate board chairman. "The quality improvement initiative is designed to reduce the risk of recurrent heart attacks by helping hospital staff follow proven evidence-based guidelines and procedures while coronary patients are in their care. "Providing the highest quality patient care is the top priority for Tenet South Florida hospitals," said Don S. Steigman, senior vice president of Tenet South Florida. "Once again, our hospitals have demonstrated their dedication to making their cardiac units among the best in the country by implementing the American Heart Association's Get With The Guid...
- Westside Gazette
- August 05, 2009
- CardioVascular BioTherapeutics Engages The Bruckner Group To Find A Joint Commercialization Partner For Its FGF-1 Protein Treatment for Cardiovascular Disease Patients.
This promising breakthrough biological therapy offers a significant likelihood of transforming cardiovascular disease treatment paradigms WAKEFIELD,...
- Business Wire
- November 27, 2007

- 'Sara Says'
Health for Peace Inc., is a California not-for-profit corporation. It teaches people about EECP to help them prevent and treat cardiovascular disease; Simple and free screenings and health education in the cpmmunity about risk factors and prevention of cardiovascular disease; Research featuring EECP that directly correlates to prevention of heart disease as well as EECP becoming the first option in treating cardiovascular disease before a heart bypass or angioplasty. To respond to the needs of people at risk for cardiovascular dis ease by making available EECP treatment to those without access to or financial means to pay for such services. Develop and implement community outreach programs featuring education and simple health screenings about a variety of topics, and support scientific...
- Sentinel; Los Angeles, Calif.
- August 27, 2009
- Women Surviving Cardiovascular Disease Treatment in Nation's Hospitals at Higher Rates, Says HealthGrades Study.
GOLDEN, Colo. -- But Three-Year Study of Women's Cardiac and Stroke Outcomes Shows 40% Lower Mortality in the Best-Performing Hospitals Compared to Po...
- Business Wire
- June 26, 2006
- Research and Markets: Cardiovascular Disease in Small Animal Medicine 2011 - Cardiac Evaluation Techniques, Investigation, Diagnosis & Treatment.
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/5ae180/cardiovascular_dis) has announced the addition of the "Cardiovascula...
- Business Wire
- February 08, 2011
- Hospital Seeks to Raise $25m
HACKENSACK -- The "A Beat Beyond" campaign at Hackensack University Medical Center has raised $10 million in an effort to create enhanced treatment for patients with cardiovascular and neurovascular disease, officials said. The medical center's foundation team said they hope to raise $25 million.
- The Record, Bergen County, NJ
- October 11, 2011
- U.S. Cardiologist Reports Successful Treatment of Cardiovascular Disease Using Patients' Own Adult Stem Cells.
Clinical Results of Adult Stem Cell Therapy Presented at International Regenerative Biomedical Technology Conference DUBAI, U.A.E. -- In a report un...
- Business Wire
- November 14, 2008
- TRx Pharma Introduces FOLMOR for the Treatment of Cardiovascular Disease.
RESEARCH TRIANGLE PARK, N.C. -- TRx Pharma announced today the availability of FOLMOR[TM] (folic acid 2.5mg, B6 25mg, B12 2mg and primorine 875mg), it...
- Business Wire
- February 06, 2007
- MIV Therapeutics Details Breakthrough Scientific Research in Transcript of Recent Investor Conference Call; Senior Executives Outline Company's Novel Coronary Stent Coatings to Improve Treatment of Cardiovascular Disease.
ATLANTA -- MIV Therapeutics (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems f...
- Business Wire
- July 17, 2006